Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.

Bagni K, Chen IM, Johansen AZ, Dehlendorff C, Jensen BV, Hansen CP, Preus Hasselby J, Holländer NH, Nissen M, Bjerregaard JK, Pfeiffer P, Yilmaz MK, Rasmussen LS, Nielsen SE, Johansen JS.

Eur J Cancer Care (Engl). 2020 Jan 6:e13219. doi: 10.1111/ecc.13219. [Epub ahead of print]

PMID:
31908093
2.

Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.

Chen IM, Johansen AZ, Dehlendorff C, Jensen BV, Bojesen SE, Pfeiffer P, Bjerregaard JK, Nielsen SE, Andersen F, Holländer NH, Yilmaz MK, Rasmussen LS, Johansen JS.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):176-184. doi: 10.1158/1055-9965.EPI-19-0672. Epub 2019 Nov 4.

PMID:
31685562
3.

Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer.

Chen IM, Willumsen N, Dehlendorff C, Johansen AZ, Jensen BV, Hansen CP, Hasselby JP, Bojesen SE, Pfeiffer P, Nielsen SE, Holländer NH, Yilmaz MK, Karsdal M, Johansen JS.

Int J Cancer. 2019 Oct 23. doi: 10.1002/ijc.32751. [Epub ahead of print]

PMID:
31642523

Supplemental Content

Loading ...
Support Center